![]() |
Volumn 156, Issue 2, 2008, Pages
|
Lipophilicity and cardiovascular outcome in patients with CHF
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN;
MEVINOLIN;
PRAVASTATIN;
ROSUVASTATIN;
SIMVASTATIN;
CEREBROVASCULAR ACCIDENT;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
DRUG TISSUE LEVEL;
DRUG UPTAKE;
HAZARD RATIO;
HEART CONTRACTION;
HEART DEATH;
HEART EJECTION FRACTION;
HEART FAILURE;
HEART INFARCTION;
HEART MUSCLE;
HUMAN;
LETTER;
LIPOPHILICITY;
MORTALITY;
PERCUTANEOUS CORONARY INTERVENTION;
PLEIOTROPY;
PRIORITY JOURNAL;
AGED;
FLUOROBENZENES;
HEART FAILURE;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPIDS;
LOVASTATIN;
PRAVASTATIN;
PYRIMIDINES;
PYRROLES;
SULFONAMIDES;
|
EID: 47649128403
PISSN: 00028703
EISSN: 10976744
Source Type: Journal
DOI: 10.1016/j.ahj.2008.04.025 Document Type: Letter |
Times cited : (11)
|
References (6)
|